Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 1
2004 1
2005 1
2010 1
2011 1
2016 1
2017 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Paranasal Sinus Squamous Cell Carcinoma"
Page 1
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC).
Cohen EEW, Bell RB, Bifulco CB, Burtness B, Gillison ML, Harrington KJ, Le QT, Lee NY, Leidner R, Lewis RL, Licitra L, Mehanna H, Mell LK, Raben A, Sikora AG, Uppaluri R, Whitworth F, Zandberg DP, Ferris RL. Cohen EEW, et al. J Immunother Cancer. 2019 Jul 15;7(1):184. doi: 10.1186/s40425-019-0662-5. J Immunother Cancer. 2019. PMID: 31307547 Free PMC article. Clinical Trial.
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, larynx and nasopharynx represent nearly 700,000 new cases and 380,000 deaths worldwide per annum, and account for over 10,000 annual deaths in the United …
Head and neck cancers, including those of the lip and oral cavity, nasal cavity, paranasal sinuses, oropharynx, larynx and nas …
Differential diagnosis and treatment options in paranasal sinus cancers.
Myers LL, Oxford LE. Myers LL, et al. Surg Oncol Clin N Am. 2004 Jan;13(1):167-86. doi: 10.1016/S1055-3207(03)00115-7. Surg Oncol Clin N Am. 2004. PMID: 15062368 Review.
Paranasal sinus malignancies are challenging to treat. Most patients present with advanced lesions, often with intracranial or intraorbital extension, and have a poor overall prognosis. Given the low incidence and diverse pathologies of paranasal sinus …
Paranasal sinus malignancies are challenging to treat. Most patients present with advanced lesions, often with intracranial or …
Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses.
Zenda S, Kohno R, Kawashima M, Arahira S, Nishio T, Tahara M, Hayashi R, Kishimoto S, Ogino T. Zenda S, et al. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1473-8. doi: 10.1016/j.ijrobp.2010.08.009. Epub 2010 Oct 18. Int J Radiat Oncol Biol Phys. 2011. PMID: 20961697
PURPOSE: The cure rate for unresectable malignancies of the nasal cavity and paranasal sinuses is low. ...Five patients (12.8%) experienced Grade 3 to 5 late toxicities, and one treatment-related death was reported, caused by cerebrospinal fluid leakage Grade …
PURPOSE: The cure rate for unresectable malignancies of the nasal cavity and paranasal sinuses is low. ...Five patients …
Outcomes of nonsurgical management of locally advanced carcinomas of the sinonasal cavity.
Chopra S, Kamdar DP, Cohen DS, Heilbrun LK, Smith D, Kim H, Lin HS, Jacobs JR, Yoo G. Chopra S, et al. Laryngoscope. 2017 Apr;127(4):855-861. doi: 10.1002/lary.26228. Epub 2016 Nov 15. Laryngoscope. 2017. PMID: 27859278 Free PMC article.
METHODS: Twenty-three nonsurgically and definitively treated patients diagnosed between July 1998 and February 2009 were analyzed. Patients with adenoid cystic carcinoma or adenocarcinoma were treated with photons and neutrons; the other histologies received photons alone. …
METHODS: Twenty-three nonsurgically and definitively treated patients diagnosed between July 1998 and February 2009 were analyzed. Patients …
Management of inverted papilloma of the nasal cavity and paranasal sinuses: importance of radiation therapy.
Hug EB, Wang CC, Montgomery WW, Goodman ML. Hug EB, et al. Int J Radiat Oncol Biol Phys. 1993 Apr 30;26(1):67-72. doi: 10.1016/0360-3016(93)90174-t. Int J Radiat Oncol Biol Phys. 1993. PMID: 8482632
METHODS AND MATERIAL: Between 1977 and 1990 25 patients were treated at the Massachusetts General Hospital and the Massachusetts Eye and Ear Infirmary with radiation therapy for inverted papilloma (seven patients) and inverted papilloma associated with squamous cell …
METHODS AND MATERIAL: Between 1977 and 1990 25 patients were treated at the Massachusetts General Hospital and the Massachusetts Eye and Ear …
Craniofacial resection for cranial base malignancies involving the infratemporal fossa.
Bilsky MH, Bentz B, Vitaz T, Shah J, Kraus D. Bilsky MH, et al. Neurosurgery. 2005 Oct;57(4 Suppl):339-47; discussion 339-47. doi: 10.1227/01.neu.0000176648.06547.15. Neurosurgery. 2005. PMID: 16234683 Free PMC article. Clinical Trial.
OBJECTIVE: Cranial base malignancies involving the infratemporal fossa have been considered unresectable. Advanced operative techniques have made tumor resection feasible in an en bloc fashion with negative histological margins, but there are limited data regarding outcome …
OBJECTIVE: Cranial base malignancies involving the infratemporal fossa have been considered unresectable. Advanced operative techniqu …
Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma.
Urba SG, Forastiere AA, Wolf GT, Esclamado RM, McLaughlin PW, Thornton AF. Urba SG, et al. J Clin Oncol. 1994 May;12(5):946-53. doi: 10.1200/JCO.1994.12.5.946. J Clin Oncol. 1994. PMID: 8164046 Clinical Trial.
The end points of the study were response rate, organ preservation, toxicity, and survival. PATIENTS AND METHODS: Forty-two eligible patients with carcinoma of the oral cavity, oropharynx, hypopharynx, larynx, and paranasal sinuses were enrolled. ...These tum …
The end points of the study were response rate, organ preservation, toxicity, and survival. PATIENTS AND METHODS: Forty-two eligible patient …
Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient.
Clark JL, Kalan GE. Clark JL, et al. J Pain Symptom Manage. 1995 May;10(4):310-4. doi: 10.1016/0885-3924(95)00010-V. J Pain Symptom Manage. 1995. PMID: 7541437 Free article.
We report the case of a 39-year-old man with severe pain due to unresectable squamous-cell carcinoma of the maxillary sinus that had invaded cranial bone and had metastasized to the cervical spine. ...
We report the case of a 39-year-old man with severe pain due to unresectable squamous-cell carcinoma of the maxi …